Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Dimerix announces positive data from phase II ACTION trials of DMX-200 in kidney disease

Oct. 28, 2020

J2H Biotech, Ahn-Gook Pharmaceutical describe new mirabegron prodrugs

Oct. 28, 2020

NOX5 is a therapeutic target in diabetic kidney disease

Oct. 9, 2020

Patient screening ongoing in phase IIa study of IP-2018

Oct. 6, 2020

CSL begins phase II study of CSL-346 in diabetic kidney disease

Oct. 2, 2020

Positive topline phase I data for ROSgard in patients with renal impairment

Sep. 30, 2020

Ultomiris approved in Japan for aHUS in adults and children

Sep. 29, 2020

Dimerix reports phase II data on DMX-200 in diabetic kidney disease

Sep. 14, 2020

Bayer initiates enrollment in phase II CONCORD study of runcaciguat

Sep. 10, 2020

First subject dosed in phase I study of ALLN-346

Sep. 9, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...